Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Chen Hua Liu, Cheng Yuan Peng, Chun Jen Liu, Chi Yi Chen, Ching Chu Lo, Kuo Chih Tseng, Pei Yuan Su, Wei Yu Kao, Ming Chang Tsai, Hung Da Tung, Hao Tsai Cheng, Fu Jen Lee, Chia Sheng Huang, Ke Jhang Huang, Yu Lueng Shih, Sheng Shun Yang, Jo Hsuan Wu, Hsueh Chou Lai, Yu Jen Fang, Po Yueh ChenJow Jyh Hwang, Chi Wei Tseng, Wei Wen Su, Chun Chao Chang, Pei Lun Lee, Jyh Jou Chen, Chi Yang Chang, Tsai Yuan Hsieh, Chung Hsin Chang, Yi Jie Huang, Jia Horng Kao
Dive into the research topics of 'Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan'. Together they form a unique fingerprint.